Global Female Fertility and Pregnancy Rapid Test Market to Witness 4.5% CAGR During 2016 - 2022: P&S Market Research

NEW YORK, April 13, 2016 /PRNewswire/ --

The global female fertility and pregnancy rapid test market is expected to grow at a CAGR of 4.5% during the period 2016 - 2022. The global market is increasing, due to growing female geriatric population and increasing incidence of uterine malformations. In addition, the growing female infertility cases, increasing cases with abnormal uterine bleeding and growing demand for easy to use at home diagnostic devices are encouraging the growth of the global female fertility and pregnancy rapid test market.

     (Logo: http://photos.prnewswire.com/prnh/20150727/756778 )

Explore Full Report on "Female fertility and pregnancy rapid test Market" at: https://www.psmarketresearch.com/market-analysis/fertility-and-pregnancy-rapid-test-market

The increasing aging population is propelling the growth of the global female fertility and pregnancy rapid test market, as the elderly population is more susceptible to gynaecological problems, such as abnormal uterine bleeding, fibroids, and polyps, as compared to adults, which is fuelling the demand  female fertility and pregnancy rapid tests. Aging leads to changes in hormones leading to irregular menses, which contribute to the demand for hormonal tests, thus driving the growth of the market.

Infertility can be a result of improper diet, poor lifestyle, consumption of alcohol, tobacco, lack of appropriate sleep, hormonal imbalance resulting in inability to conceive. For instance as reported by American Pregnancy Association (APA), infertility affects approximately 1 out of every 6 couples and female infertility accounts for about one-third of all infertility cases. Furthermore, as reported by CDC, about 12% of women between the age group 15-44 years of age in the U.S. have difficulty in getting pregnant or carrying a pregnancy.

Request for Report Sample: https://www.psmarketresearch.com/market-analysis/fertility-and-pregnancy-rapid-test-market/report-sample

The advantageous features possessed by these at home pregnancy and fertility rapid test attract the patients around the world to opt for such easy to use devices instead of going for a lab based test. At home fertility and pregnancy rapid test are time saving, comparatively economical, helps maintain privacy and can be used by the females at the comfort of their home; thus, generating a high demand for at home diagnostic devices fuelling the growth of the global female fertility and pregnancy rapid test market.

Browse Related Reports: https://www.psmarketresearch.com/industry-report/medical-devices

However, the availability of alternative diagnostic test such as blood test and reagent based laboratory test are inhibiting the growth of the global female fertility and pregnancy rapid test market. In addition, the high cost of midstreams, in comparison to strips/dipsticks and cassettes/cards make them less affordable by the patient pool is further restraining the growth of the market. The Asian market is expected to witness the fastest growth during the period 2016 - 2022.

The key companies operating in the global female fertility and pregnancy rapid test market include Alere Inc., Atlas Medical, Diagnostic Automation/Cortez Diagnostics Inc., BioMerieux SA, SA Scientific, Church & Dwight Co., Inc.., Nantong Egens Biotechnology Co. Ltd., and Gemc Technology Group Co., Ltd.

GLOBAL FEMALE FERTILITY AND PREGNANCY RAPID TEST MARKET SEGMENTATION 

By Type of Test 

• Luteinizing hormone (LH) Female fertility rapid tests
• Follicle Stimulating Hormone (FSH) Female fertility rapid tests
• Human Chorionic Gonadotropin (HCG) Pregnancy rapid tests

By Product 

• Strips/Dipsticks
  • Luteinizing hormone (LH)
  • Follicle Stimulating Hormone (FSH)
  • Human Chorionic Gonadotropin (HCG)
• Cards/Cassettes
  • Luteinizing hormone (LH)
  • Follicle Stimulating Hormone (FSH)
  • Human Chorionic Gonadotropin (HCG)
• Midstreams
  • Luteinizing hormone (LH)
  • Follicle Stimulating Hormone (FSH)
  • Human Chorionic Gonadotropin (HCG)

By Geography 

• North America- The U.S., Canada, and Rest of North America
• Europe- The U.K, Germany, France, Italy, Spain, and Rest of Europe
• Asia- China, Japan, India, and Rest of Asia
• Rest of the World (RoW)- Brazil, Australia, and Others

Browse Other Reports BY P&S Market Research 

Global Neurostimulation Devices Market- https://www.psmarketresearch.com/market-analysis/neurostimulation-devices-market

Global Self-Monitoring Blood Glucose (SMBG) Devices Market - https://www.psmarketresearch.com/market-analysis/self-monitoring-blood-glucose-market

Global Hysteroscope Market - https://www.psmarketresearch.com/market-analysis/hysteroscopes-market

About P&S Market Research 

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we're keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
Abhishek
Executive - Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: [email protected]

Web: https://www.psmarketresearch.com

SOURCE P&S Market Research